A process for alkylation of a N′-phenyl-n-alkyl-p-phenylenediamine of specified formula in an ionic liquid unexpectedly produces a N′-phenyl-n-alkyl(alkylphenylene)diamine of a second specified formula. The use of an inorganic liquid permits convenient separation of the alkylated reaction product from the reaction mixture.

Patent
   7563929
Priority
Dec 14 2005
Filed
Apr 16 2008
Issued
Jul 21 2009
Expiry
Dec 14 2025

TERM.DISCL.
Assg.orig
Entity
Large
50
14
EXPIRED
1. A process for alkylating a N′-phenyl-n-alkylphenylenediamine comprising reacting a N′-phenyl-n-alkylphenylenediamine of Formula I
##STR00007##
wherein R1 is an alkyl group or an arylalkyl group,
with an alkylating agent in the presence of an ionic liquid comprising a lewis acid and a quatemary cation, to produce a N′-phenyl-n-alkyl(alkylphenylene)diamine of the Formula II
##STR00008##
wherein R1 is as defined above, and
R2 is a substituted or unsubstituted linear, branched or cyclic alkyl group or an alkylaryl group.
2. The process of claim 1, wherein said alkylating agent is a substituted or unsubstituted linear, branched or cyclic olefin or an arylalkene.
3. The process of claim 2, wherein said olefin is a linear olefin selected from the group consisting of 1-hexene, 1-nonene, 1 decene and 1-dodecene.
4. The process of claim 2, where said olefin is a cylcic olefin selected from the group consisting of cyclohexene, cyclopentene and cyclooctane.
5. The process of claim 2, wherein said olefin is a branched olefin selected from the group consisting of propylene trimer, propylene tetramer, propylene pentamer and diisobutylene.
6. The process of claim 2, wherein said olefin is an arylalkene selected from the group consisting of styrene, methyl styrene, 3-phenylpropene and 2-phenyl-2-butene.
7. The process of claim 1, wherein said lewis acid is a metal halide selected from the group consisting of aluminum chloride, aluminum bromide, indium trichloride, gallium trichloride, niobium pentachloride, tantalum pentachloride, titanium tetrachloride, boron trifluoride, boron trifluoride etherate, boron trichloride, ferric chloride, and zirconium chloride.
8. The process of claim 1, wherein said lewis acid is an alkyl halide selected from the group consisting of methyl chloride, methyl bromide, methyl iodide, ethyl chloride, ethyl bromide, ethyl iodide, n-propyl chloride, n-propyl bromide, n-propyl iodide, isopropyl chloride, isopropyl bromide, isopropyl iodide, n-butyl chloride, n-butyl bromide, n-butyl iodide, isobutyl chloride, isobutyl bromide, isobutyl iodide, tert-butyl chloride, tert-butyl bromide, tert-butyl iodide, n-pentyl chloride, n-pentyl bromide, n-pentyl iodide, neopentyl bromide, neopentyl chloride, neopentyl iodide, octyl chloride, octyl bromide and octyl iodide.
9. The process of claim 1, wherein said lewis acid is an alkylaryl halide selected from the group consisting of benzyl bromide, benzyl chloride, benzyl iodide, α-phenylethyl chloride, α-phenylethyl bromide, α-phenylethyl iodide, β-phenylethyl chloride, β-phenylethyl bromide, and β-phenylethyl iodide.
10. The process of claim 1, wherein said lewis acid is an alkyl sulfonate ester.
11. The process of claim 1, wherein said quatemary cation is selected from a quatemary ammonium cation, an alkylphoshonium cation, an alkylimidazolium cation, an alkyltriazolium cation and an alkylpyridinium cation.
12. The process of claim 11, wherein said quatemary ammonium cation is a member selected from the group consisting of benzyltrimethylammonium, butyltrimethylammonium, methyltriethylammonium, ethyltrimethylammonium, tetra-n-butylammonium, n-hexyl-trimethylammonium, n-heptyl-trimethylammonium, n-octyl-trimethyammonium, n-hexyltriethyammonium, n-heptyl-triethylammonium, n-octyl-triethylammonium, n-hexyl-tri-n-butylammonium, n-heptyl-n-butylammonium, n-octyl-tri-n-butylammonium, tris-(n-propyl)-undecylammonium, tetra-n-pentylammonium, n-decyl-n-octyl-dimethylammonium and n-tetradecyl-triethyammonium.
13. The process of claim 11, wherein said alkylphosphonium cation is selected from the group of benzyltrimethylphosphoniom, butyltrimethylphosphoniom, methyltriethyiphosphoniom, ethyltrimethylphosphonium, tetra-n-butylphosphonium, n-hexyl-trimethylphosphonium, n-heptyl-trimethylphosphonium, n-octyl-trimethylphosphonium, n-hexyl-triethylphosphonium, n-heptyl-triethylphosphonium, n-octyl-triethylphosphonium, n-hexyl-tri-n-butylphosophonium, n-heptyl-tri-n-butylphosophonium, n-octyl-tri-n-butylphosophonium, tris-(n-propyl)-undecylphosphonium, tetra-n-pentylphosphonium, n-decyl-n-octyl-dimethylphosphonium and n-tetradecyl-triethylphopsphonium.
14. The process of claim 11, wherein said alkylimidaxolium cation is a member selected form the group consisting of 1-methyl-2-methylimidazolium, 1-ethyl-3-methyl-imidazolium, 1-butyl-3-methyl-imidazolium, 1-dodecyl-5-methyl-imidazolium, 1-(2,2,2-trifluoroethyl)-3-methylimidazolium, 1-(ethoxymethyl)-3-methylimidazolium, 3-ethyl-1-ethylimidazolium, 3-ethyl-1-butylimidazolium, 1-ethyl-2,3-dimethyl-imidazolium, 1,2-diethyl-3-methylimidazolium, 1-ethyl-3,5-dimethyl-imidazolium and 1,3-diethyl-5-methylimidazolium.
15. The process of claim 11, wherein said alkyltriazolium cation is a member selected from the group consisting of 1-(3′,3′,3′-trifluoro-n-propyl)-3-n-butyl-1,2,4-triazolium, 1-(2′-fluoroethyl)-3-n-heptyl-1,2,4-triazolium, 1-(2′-fluoroethyl)-3-n-3-decyl-1,2,4-trizolium, 1-(1H,1H,2H,2H-perfluoro-n-hexyl)-3-n-butyl-1,2,4-triazolium, 1-n-propyl-4-amino-1,2,4-triazolium, 1-n-butyl-4-amino-1,2,4-triazolium and 1-n-hexyl-4-amino-1,2,4-triazolium.
16. The process of claim 1, wherein said ionic liquid is formed in situ prior to addition of said alkylating agent.
17. The process of claim 1, performed at a temperature of from 80 to 200° C. over a time period of from 1 to 24 hours.
18. The process of claim 1, performed under an inert atmosphere selected from the group consisting of argon, helium and nitrogen.
19. The process of claim 1, performed with stirring at a stirring speed of from 200 to 300 rpm.

This application is a continuation of U.S. application Ser. No. 11/304,829 filed Dec. 14, 2005, now U.S. Pat. No. 7,390,928, which is incorporated herein by reference in its entirety.

N′-phenyl-N-alkylphenylenediamines have utility as antioxidants for lubricant oils, rubber compositions and antiozonants. U.S. Pat. No. 5,232,614 discloses the use of N,N′-dialkylsubstituted p-phenylenediamines as antioxidants in lubricating oils.

The Friedel-Crafts alkylation of N′-phenyl-N-phenylenediamine compounds using alpha-olefins and a Lewis acid catalyst such as aluminum chloride provides little or no yield of alkylated product. Instead, an aluminum alkyl catalyst and high pressure may be used to alkylate N′-phenyl-N-phenylenediamines.

The use of aluminum alkyls to alkylate a N′-phenyl-N-alkylphenylenediamine has at least two disadvantages: the compounds are not recyclable, and they may spontaneously ignite in air. Moreover, the reaction typically alkylates the non-substituted phenyl ring. Thus, for example, the use of triethylaluminum chloride, heat and pressure to alkylate N′-phenyl-N-isohexylphenylenediamine with 1-decene produces predominantly N′-2-methylnonylphenyl-N-isohexylphenylenediamine.

An ionic liquid consists of inorganic and/or organic cations and anions, and typically has a very low vapor pressure, a wide liquid temperature range, and is non-flammable. Ionic liquids can act as a catalyst and/or solvent, and have been studied for utility as solvents, electrolytes, in separations and in fluid applications such as lubricants. See Holbrey, “Industrial Applications of Ionic Liquids,” Chemistry Today 35 (June 2004); Parkinson, “Ionic Liquids Make an Environmental Splash,” 100 Chemical Engineering Progress 7 (September 2004); and Drake et al., “Structural Effects on the Physical Properties of Ionic Liquids,” Air Force Research Laboratory Report No. AFRL-PR-ED-VG-2003-12 (May 2003).

The use of ionic liquids in Friedel-Crafts alkylation has been discussed in Wilkes, Friedel-Crafts Reactions in Chloroaluminate Molten Salts,” Molten Salt Chemistry: An Introduction and Selected Applications 405 (Mamantov and Marassi Eds. 1987) and Earle et al, “Organic Synthesis,” Ionic Liquids in Synthesis 174 (Wasserschied & Welton Eds. 2003). However, neither study is directed to an alkylation reaction which permits further substitution of the phenylene ring of an N′-phenyl-N-alkylphenylenediamine compound.

An object of the invention is to provide a synthesis which permits alkylation of the phenylene ring of an N′-phenyl-N-phenylenediamine compound.

A feature of the invention is the use of an ionic liquid as a solvent and catalyst for the alkylation reaction.

An advantage of the invention is that use of an ionic liquid typically permits convenient separation of N′-phenyl-N-alkyl(alkylphenylene)diamine from the reaction mixture.

In one aspect, the present invention relates to a process for alkylating a N′-phenyl-N-alkylphenylenediamine, comprising

reacting a N′-phenyl-N-alkylphenylenediamine of Formula I

##STR00001##

wherein R1 is an alkyl group or an arylalkyl group,

with an alkylating agent in the presence of an ionic liquid comprising a Lewis acid and a quaternary cation,

to produce a N′-phenyl-N-alkyl(alkylphenylene)diamine of Formula II

##STR00002##

wherein R1 is as defined above, and

R2 is a substituted or unsubstituted linear, branched or cyclic alkyl group or an alkylaryl group.

In another aspect, the present invention relates to a N′-phenyl-N -alkyl(alkylphenylene)diamine of Formula II

##STR00003##

wherein R1 is an alkyl group or an arylalkyl group; and

R2 is a substituted or unsubstituted linear, branched or cyclic alkyl group or an alkylaryl group, prepared by a process comprising:

reacting a N′-phenyl-N-alkylphenylenediamine of Formula I

##STR00004##

wherein R1 is an alkyl group or an arylalkyl group,

with an alkylating agent in the presence of an ionic liquid comprising a Lewis acid and a quaternary cation.

In yet another aspect, the present invention relates to a lubricant composition comprising a lubricating oil and a N′-phenyl-N-alkyl(alkylphenylene)diamine of Formula II

##STR00005##

wherein R1 is an alkyl group or an arylalkyl group; and

R2 is a substituted or unsubstituted linear, branched or cyclic alkyl group or an alkylaryl group.

As summarized above, the present invention relates to the Friedel-Crafts alkylation of a N′-phenyl-N-alkylphenylenediamine in the presence of an inorganic liquid.

The alkylating agent may be a substituted or unsubstituted linear, branched or cyclic olefin or an arylalkene. Suitable linear olefins include 1-hexene, 1-nonene, 1-decene and 1-dodecene. Suitable cyclic olefins include cyclohexene, cyclopentene and cyclooctene. Suitable branched olefins include propylene trimer (nonenes), propylene tetramer (dodecenes), propylene pentamer and diisobutylene. Suitable arylalkylenes include styrene, methyl styrene, 3-phenylpropene and 2-phenyl-2-butene.

The ionic liquid may be composed entirely of anions and cations, and may conveniently be prepared by mixing together a Lewis acid and an alkyl quaternary metal salt, preferably under heat.

The Lewis acid may be a metal halide, an alkyl halide, an alkylaryl, or an alkyl sulfonate ester. Suitable Lewis acid metal halides include aluminum chloride, aluminum bromide, indium trichloride, gallium trichloride, niobium pentachloride, tantalum pentachloride, titanium tetrachloride, boron trifluoride, boron trifluoride etherate, boron trichloride, ferric chloride, and zirconium chloride. Illustrative alkyl halides include methyl chloride, methyl bromide, methyl iodide, ethyl chloride, ethyl bromide, ethyl iodide, n-propyl chloride, n-propyl bromide, n-propyl iodide, isopropyl chloride, isopropyl bromide, isopropyl iodide, n-butyl chloride, n-butyl bromide, n-butyl iodide, isobutyl chloride, isobutyl bromide, isobutyl iodide, tert-butyl chloride, tert-butyl bromide, tert-butyl iodide, n-pentyl chloride, n-pentyl bromide, n-pentyl iodide, neopentyl bromide, neopentyl chloride, neopentyl iodide, octyl chloride, octyl bromide and octyl iodide. Illustrative alkylaryl halides include benzyl bromide, benzyl chloride, benzyl iodide, α-phenylethyl chloride, α-phenylethyl bromide, α-phenylethyl iodide, β-phenylethyl chloride, β-phenylethyl bromide and β-phenylethyl iodide. Suitable alkyl sulfonate esters include alkyl tosylates, alkyl mesylates and alkyl triflates.

The alkyl quaternary metal salt may be a quaternary ammonium salt, an alkylphosphonium salt, an alkylimidazolium salt, an alkyltriazolium salt and an alkylpyridinium salt. Suitable quaternary ammonium salts may be based on cations selected from the group consisting of benzyltrimethylammonium, butyltrimethylammmonium, methyltriethylammonium, ethyltrimethylammonium, tetra-n-butylammonium, n-hexyl-trimethylammonium, n-heptyl-trimethylammonium, n-octyl-trimethylammonium, n-hexyl-triethylammonium, n-heptyl-triethylammonium, n-octyl-triethylammonium, n-hexyl-tri-n-butylammonium, n-heptyl-tri-n-butylammonium, n-octyl-tri-n-butylammonium, tris-(n-propyl)-undecylammonium, tetra-n-pentylammonium, N-decyl-n-octyl-dimethylammonium and N-tetradecyl-triethylammonium.

Suitable alkylphosphonium salts may be based on cations selected from the group of benzyltrimethylphosphonium, butyltrimethylphosphonium, methyltriethylphosphonium, ethyltrimethylphosphonium, tetra-n-butylphosphonium, n-hexyl-trimethylphosphonium, n-heptyl-trimethylphosphonium, n-octyl-trimethylphosphonium, n-hexyl-triethylphosphonium, n-heptyl-triethylphosphonium, n-octyl-triethylphosphonium, n-hexyl-tri-n-butylphosphonium, n-heptyl-tri-n-butylphosphonium, n-octyl-tri-n-butylphosphonium, tris-(n-propyl)-undecylphosphonium, tetra-n-pentylphosphonium, N-decyl-n-octyl-dimethylphosphonium and N-tetradecyl-triethylphosphonium.

Suitable imidazolium salts may be based on cations selected from the group consisting of 1-methyl-3-methyl-imidazolium, 1-ethyl-3-methyl-imidazolium, 1-butyl-3-methylimidazolium, 1-dodecyl-5-methylimidazolium, 1-(2,2,2-trifluoroethyl)-3-methylimidazolium, 1-(ethoxymethyl)-3-methylimidazolium, 3-ethyl-1-ethylimidazolium, 3-ethyl-l-butyl-imidazolium, 1-ethyl-2,3-dimethyl-imidazolium, 1,2-diethyl-3-methylimidazolium, 1-ethyl-3,5-dimethyl-imidazolium and 1,3-diethyl-5-methylimidazolium.

Suitable alkyltriazonium salts may be based on cations selected from the group consisting of 1-(3′,3′,3′-trifluoro-n-propyl)-3-n-butyl-1,2,4-triazolium, 1-(2′-fluoroethyl)-3-n-heptyl-1,2,4-triazolium, 1-(2′-fluoroethyl)-3-n-decyl-1,2,4-triazolium, 1-(1H,1H,2H,2H-perfluoro-n-hexyl)-3-n-butyl-1,2,4-triazolium, 1-n-propyl-4-amino-1,2,4-triazolium, 1-n-butyl-4-amino-1,2,4-triazolium and 1-n-hexyl-4-amino-1,2,4-triazolium.

In a preferred embodiment, the ionic liquid is formed in situ prior to addition of the alkylating agent. The Lewis acid, alkyl quaternary metal salt and N′-phenyl-N-alkylphenylenediamine may be added to a suitable reaction vessel, preferably under a dry, inert atmosphere and with heating to a temperature up to 200° C., and stirred, for example at 200 to 300 rpm, until an ionic liquid phase and an organic phase are formed. The inert atmosphere serves to protect the ionic liquid from oxidation, and is preferably selected from the group consisting of argon, helium and nitrogen. The inert atmosphere should also be dry to avoid decomposition of the ionic liquid.

The alkylating agent may be added to the reaction vessel once the two phases have been formed, either all at once or by multiple partial additions.

The alkylation reaction may preferably be performed at a temperature of from 80 to 200° C. over a time period of from 1 to 24 hours.

The alkylation reaction produces a mixture of mono, di and tri-alkylated N′-phenyl-N-alkylphenylenediamines. The reaction products may be separated from the reactants by conventional separation techniques and apparatus, such as a separatory funnel well known to one of ordinary skill in the art. Similarly, the isolated reaction mixture may be separated into its component compounds using conventional separation techniques and apparatus well known to those of ordinary skill in the art, such as, for example, high pressure liquid chromatography.

The Friedel-Crafts alkylation of N′-phenyl-N-alkylphenylene-diamine in an ionic liquid as described above unexpectedly produces a N′-phenyl-N-alkyl(alkylphenylene)diamine of formula II:

##STR00006##

wherein R1 is an alkyl group or an arylalkyl group, preferably having from 1 to 30 carbon atoms; and

R2 is a substituted or unsubstituted linear, branched or cyclic alkyl group or an alkylaryl group, preferably having from 1 to 30 carbon atoms.

Preferred N′-phenyl-N-alkyl(alkylphenylene)diamine compounds include those in which R1 and R2 are both n-2-decyl, where R1 is 2-isohexyl and R2 is n-2-decyl, and where at least one of R1 and R2 is an arylalkyl group.

The N′-phenyl-N-alkyl(alkylphenylene)diamine compounds prepared by the process of the present invention are believed suitable for use as antioxidants in lubricant compositions such as those described in U.S. Pat. No. 5,232,614, the disclosure of which is hereby incorporated by reference in its entirety. Typically, the lubricant composition will include at least a lubricating oil and at least one N′-phenyl-N-alkyl (alkylphenylene)diamine as an antioxidant. However, the composition may also include one or more members of the group consisting of a dispersant, a detergent, an antiwear additive, a pour point depressant, a corrosion inhibitor and a friction modifier.

The lubricating oil may be a hydrocarbon oil derived from petroleum or a long chain hydrocarbon substituted with an alpha-or beta-unsaturated carboxylic acid. The detergent, when present, may be an alkali metal sulfonate, an alkaline earth metal sulfonate or a metal salt of a sulfur-containing alkylphenol compound.

The antiwear additive, when present, may be an organic sulfide, a polysulfide, an ester of beta-thiodipropionic acid, a phosphorus ester or a dihydrocarbyl dithiophosphate metal salt.

The corrosion inhibitor, when present, may be a benzotriazole derivative, a thiadiazole compound, a mercaptobenzothioazole compound in the form of an amine salt, a sulfonamide, a thiosulfonamide, a condensate of mercaptobenzothiazole with an amine and formaldehyde, a dialkylphosphite, a trialkylphosphite or a triarylphosphite.

The friction modifier, when present, may be a glyceryl monoester of a higher fatty acid or an oxazoline compound.

The inventors currently believe the ionic liquid may be recycled for use in subsequent alkylations by simple phase separation in which the hydrocarbon-soluble reaction product is decanted, and thus separated from, the denser ionic liquid phase.

The ionic liquid may then be used to catalyze another alkylation reaction by itself, or in combination with fresh catalyst.

The following Example illustrates the practice and advantages of the invention in greater detail with respect to an individual species thereof. The details of the example are illustrative only, and are not to be used to constrict the scope of the claims.

A 1-L, 4-necked round bottomed flask equipped with a mantle, temperature controller, thermocouple, and pressure equilibrated dropping funnel was charged under nitrogen positive pressure with solid N′-phenyl-N-2-isohexyl-p-phenylenediamine (53.38 g, 0.1989 mole) commercially available as Flexzone 7P from Chemtura Corp., aluminum chloride (13.37 g, 0.100 mole, 50.4 mole % relative to N′-phenyl-N-2-isohexyl-p-phenylenediamine) and tetra-n-butylammonium bromide (21.34 g, 0.0661 mole, 33.3 mole % relative to N′-phenyl-N-2-isohexyl-p-phenylenediamine). Stirring was started at ca. 200-300 rpm and the mixture warmed to 160° C.

When the dark brown-black reaction mixture had reached 160° C., 94% 1-decene (97.64 g, 0.696 mole, 3.5 equiv. relative to N′-phenyl-N-2-isohexyl-p-phenylenediamine) was added over 2 hr. The reaction mixture was brought to 170° C. upon completion of the addition and maintained at this temperature for 25 hr.

The reaction product was then allowed to cool down to ambient temperature and was diluted with 300 mL n-heptane. The dark brown-black reaction mixture separated into a lower solid phase and an upper liquid phase, which was decanted into a 2-L separatory funnel, washed with 2× 500 mL water and then 400 mL water-100 mL conc. aqueous ammonia, and then dried over anhydrous sodium sulfate. The solid phase at the bottom of the flask weighed 50.74 g.

The drying agent was removed from the product by suction filtration through a 9.0 cm diameter disk of 934 AH glass fiber paper. The dark filtrate was then condensed in vacuo (rotary evaporator, 95° C. water bath, <5 mm final vacuum) to obtain 49.49 g of a dark brown-black oil.

GC analysis of the oil indicated that it was a mixture of (area %) 17.1% unreacted N′-phenyl-N-2-isohexyl-p-phenylenediamine, 71.8% mono-decylated N′-phenyl-N-2-isohexyl-p-phenylenediamine and 7.5% multi-decylated N′-phenyl-N-2-isohexyl-p-phenylenediamine. The monodecylated product was a mixture of two isomers: 8.2% and 63.6%. The major isomer was isolated by column chromatography.

The major isomer was identified as N′-phenyl-N-2-isohexyl-[2-(2-isodecyl)-p-phenylene)]diamine (GRFE) by its GC retention time, IR spectra and NMR spectra, which were consistent with the GC retention time, IR spectra and NMR spectra of an authentic GRFE sample prepared using a different synthesis route, i.e., from 1-decene using diethyl aluminum chloride as a catalyst, heat and high pressure.

The inventors currently believe the ionic liquid may be recycled for use in subsequent alkylations by simple phase separation in which the hydrocarbon-soluble reaction product(s) is/are decanted, and thus separated from, the denser ionic liquid phase. The ionic liquid may then be used to catalyze another alkylation reaction by itself, or in combination with fresh catalyst.

Hobbs, Steven J., Stieber, Joseph F.

Patent Priority Assignee Title
10160718, Dec 22 2015 FLEXSYS HOLDINGS, INC Methods of making compounds having antidegradant and antifatigue efficacy
10160845, Dec 22 2015 FLEXSYS HOLDINGS, INC Methods of making compounds and mixtures having antidegradant and antifatigue efficacy
10167252, Dec 22 2015 FLEXSYS HOLDINGS, INC Compounds and mixtures with antidegradant and antifatigue efficacy and compositions including such compounds
10258790, Dec 03 2014 Helius Medical, Inc Systems for providing non-invasive neurorehabilitation of a patient
10260017, Dec 22 2015 FLEXSYS HOLDINGS, INC Compounds and mixtures with antidegradant and antifatigue efficacy and compositions including said compounds
10287418, Dec 22 2015 FLEXSYS HOLDINGS, INC Compounds with antidegradant and antifatigue efficacy and compositions including said compounds
10293163, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
10328263, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
10407562, Dec 22 2015 FLEXSYS HOLDINGS, INC Compounds with antidegradant and antifatigue efficacy and compositions including said compounds
10428009, Dec 22 2015 FLEXSYS HOLDINGS, INC Methods of making compounds and mixtures having antidegradant and antifatigue efficacy
10463850, Dec 03 2014 Helius Medical, Inc Methods of manufacturing devices for the neurorehabilitation of a patient
10611719, Dec 22 2015 FLEXSYS HOLDINGS, INC Methods of making compounds and mixtures having antidegradant and antifatigue efficacy
10709887, Dec 03 2014 Helius Medical, Inc Devices for delivering non-invasive neuromodulation to a patient
11185696, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
11197994, Dec 03 2014 Helius Medical, Inc Systems for providing non-invasive neurorehabilitation of a patient
11285325, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
8849407, Jan 04 2008 ADVANCED NEUROREHABILITATION, LLC Non-invasive neuromodulation (NINM) for rehabilitation of brain function
8909345, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
9020612, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
9072889, Dec 03 2014 Helius Medical, Inc Systems for providing non-invasive neurorehabilitation of a patient
9227051, Dec 03 2014 Helius Medical, Inc Devices for delivering non-invasive neuromodulation to a patient
9272133, Dec 03 2014 Helius Medical, Inc Methods of manufacturing devices for the neurorehabilitation of a patient
9283377, Dec 03 2014 Helius Medical, Inc Devices for delivering non-invasive neuromodulation to a patient
9415209, Dec 03 2014 Helius Medical, Inc Methods of manufacturing devices for the neurorehabilitation of a patient
9415210, Dec 03 2014 Helius Medical, Inc Methods of manufacturing devices for the neurorehabilitation of a patient
9597501, Jan 04 2008 Neurohabilitation Corporation Non-invasive neuromodulation (NINM) for rehabilitation of brain function
9597504, Jan 04 2008 Neurohabilitation Corporation Non-invasive neuromodulation (NINM) for rehabilitation of brain function
9616222, Dec 03 2014 Helius Medical, Inc Systems for providing non-invasive neurorehabilitation of a patient
9656060, Dec 03 2014 Helius Medical, Inc Methods of manufacturing devices for the neurorehabilitation of a patient
9656069, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
9656078, Jan 04 2008 Non-invasive neuromodulation (NINM) for rehabilitation of brain function
9789306, Dec 03 2014 Helius Medical, Inc Systems and methods for providing non-invasive neurorehabilitation of a patient
9981127, Dec 03 2014 Helius Medical, Inc Systems and methods for providing non-invasive neurorehabilitation of a patient
9993640, Dec 03 2014 Helius Medical, Inc Devices for delivering non-invasive neuromodulation to a patient
D749746, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D750264, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D750265, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D750266, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D750267, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D750268, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D750794, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D751213, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D751214, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D751722, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D752236, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D752766, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D753315, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D753316, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D759830, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
D760397, Dec 03 2014 Helius Medical, Inc Non-invasive neurostimulation device
Patent Priority Assignee Title
2943112,
4824601, Dec 08 1983 Ciba Specialty Chemicals Corporation Liquid antioxidant produced by alkylating diphenylamine with a molar excess of diisobutylene
4973759, Oct 07 1988 Bayer Aktiengesellschaft Process for the isolation of alkylated aromatic amines
5214211, Dec 12 1991 UOP Alkylation of diarylamines with olefins using rare earth modified pillared clays
5232614, Feb 23 1989 Exxon Chemical Patents Inc. Lubricating oil compositions and additives for use therein
5672752, Sep 13 1995 EMERALD POLYMER ADDITIVES, LLC Liquid alkylated diphenylamine antioxidant
5734084, Dec 17 1996 The Lubrizol Corporation; LUBRIZOL CORPORATION, THE Synthesis of alkylated aromatic amines
5750787, Sep 13 1995 EMERALD POLYMER ADDITIVES, LLC Liquid alkylated diphenylamine antioxidant
5994602, Feb 10 1994 BP Chemicals Limited Alkylation process
6315925, Jun 06 1997 Ciba Specialty Chemicals Corporation Nonylated diphenylamines
7145038, Dec 14 2005 LANXESS SOLUTIONS US INC Alkylation of a diphenylamine compound in ionic liquid
EP807620,
GB2325929,
JP55053249,
//////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 16 2008Chemtura Corporation(assignment on the face of the patent)
Feb 12 2010GREAT LAKES CHEMICAL GLOBAL, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010Great Lakes Chemical CorporationCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010GLCC LAUREL, LLCCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010CROMPTON MONOCHEM, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010CROMPTON HOLDING CORPORATIONCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010CROMPTON COLORS INCORPORATEDCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010CNK CHEMICAL REALTY CORPORATIONCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010BIO-LAB, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010BIOLAB TEXTILE ADDITIVES, LLCCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010ASCK, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010BIOLAB FRANCHISE COMPANY, LLCCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010BIOLAB COMPANY STORE, LLCCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010ASEPSIS, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010AQUA CLEAR INDUSTRIES, LLCCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010A & M CLEANING PRODUCTS, LLCCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010Chemtura CorporationCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010GT SEED TREATMENT, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010HOMECARE LABS, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010WRL OF INDIANA, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010WEBER CITY ROAD LLCCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010UNIROYAL CHEMICAL COMPANY LIMITED DELAWARE CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010NAUGATUCK TREATMENT COMPANYCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010RECREATIONAL WATER PRODUCTS, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010MONOCHEM, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010KEM MANUFACTURING CORPORATIONCITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010LAUREL INDUSTRIES HOLDINGS, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Feb 12 2010ISCI, INC CITIBANK, N A AMENDED AND RESTATED INTELLECTUAL PROPERTY SECURITY AGREEMENT0239980001 pdf
Nov 10 2010CROMPTON HOLDING CORPORATIONBANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010CITIBANK, N A Chemtura CorporationINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010WEBER CITY ROAD LLCBANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010Great Lakes Chemical CorporationBANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010GREAT LAKES CHEMICAL GLOBAL, INC BANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010GT SEED TREATMENT, INC BANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010CITIBANK, N A Great Lakes Chemical CorporationINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010HOMECARE LABS, INC BANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010LAUREL INDUSTRIES HOLDINGS, INC BANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010RECREATIONAL WATER PRODUCTS, INC BANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010CITIBANK, N A A & M CLEANING PRODUCTS, LLCINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A ASCK, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A BIOLAB COMPANY STORE, LLCINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A RECREATIONAL WATER PRODUCTS, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A WEBER CITY ROAD LLCINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A WRL OF INDIANA, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A BIOLAB FRANCHISE COMPANY, LLCINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010Chemtura CorporationBANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010BIOLAB FRANCHISE COMPANY, LLCBANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010BIO-LAB, INC BANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010CROMPTON COLORS INCORORATEDBANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010CLCC LAUREL, LLCBANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010Great Lakes Chemical CorporationBANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010GREAT LAKES CHEMICAL GLOBAL, INC BANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010GT SEED TREATMENT, INC BANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010HOMECARE LABS, INC BANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010HAOMECARE LABS, INC BANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010LAUREL INDUSTRIES HOLDINGS, INC BANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010CITIBANK, N A MONOCHEM, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A UNIROYAL CHEMICAL COMPANY LIMITED DELAWARE INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A NAUGATUCK TREATMENT COMPANYINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A AQUA CLEAR INDUSTRIES, LLCINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A ASEPSIS, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A BIOLAB TEXTILES ADDITIVES, LLCINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A BIOLAB, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A CROMPTON COLORS INCORPORATEDINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A CROMPTON MONOCHEM, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A CNK CHEMICAL REALTY CORPORATIONINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A CROMPTON HOLDING CORPORATIONINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A GLCC LAUREL, LLCINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A GT SEED TREATMENT, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A ISCI, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A GREAT LAKES CHEMICAL GLOBAL, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A HOMECARE LABS, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A KEM MANUFACTURING CORPORATIONINTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010CITIBANK, N A LAUREL INDUSTRIES HOLDINGS, INC INTELLECTUAL PROPERTY SECURITY RELEASE AGREEMENT0260390142 pdf
Nov 10 2010RECREATIONAL WATER PRODUCTS, INC BANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010GLCC LAUREL, LLCBANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010CROMPTON HOLDING CORPORATIONBANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010WEBER CITY ROAD LLCBANK OF AMERICA, N A SECDOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0278810347 pdf
Nov 10 2010Chemtura CorporationBANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010BIOLAB FRANCHISE COMPANY, LLCBANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010BIO-LAB, INC BANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Nov 10 2010CROMPTON COLORS INCORPORATEDBANK OF AMERICA, N A FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0260280622 pdf
Jan 31 2014CROMPTON COLORS INCORPORATEDBANK OF AMERICA, N A THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0333600325 pdf
Jan 31 2014Great Lakes Chemical CorporationBANK OF AMERICA, N A THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0333600325 pdf
Jan 31 2014GLCC LAUREL, LLCBANK OF AMERICA, N A THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0333600325 pdf
Jan 31 2014Chemtura CorporationBANK OF AMERICA, N A THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0333600325 pdf
Jan 31 2014Great Lakes Chemical CorporationBANK OF AMERICA, N A AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERY SECURITY AGREEMENT0333600225 pdf
Jan 31 2014GLCC LAUREL, LLCBANK OF AMERICA, N A AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERY SECURITY AGREEMENT0333600225 pdf
Jan 31 2014CROMPTON COLORS INCORPORATEDBANK OF AMERICA, N A AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERY SECURITY AGREEMENT0333600225 pdf
Jan 31 2014Chemtura CorporationBANK OF AMERICA, N A AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERY SECURITY AGREEMENT0333600225 pdf
Apr 21 2017BANK OF AMERICA, N A LAUREL INDUSTRIES HOLDINGS, INC RELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A HOMECARE LABS, INC RELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A GT SEED TREATMENT, INC RELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A GREAT LAKES CHEMICAL GLOBAL, INC RELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A GLCC LAUREL, LLCRELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A Great Lakes Chemical CorporationRELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017LANXESS SOLUTIONS US INC LANXESS SOLUTIONS US INC MERGER AND CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0468110266 pdf
Apr 21 2017BANK OF AMERICA, N A CROMPTON HOLDING CORPORATIONRELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017Chemtura CorporationLANXESS SOLUTIONS US INC MERGER AND CHANGE OF NAME SEE DOCUMENT FOR DETAILS 0468110266 pdf
Apr 21 2017BANK OF AMERICA, N A BIO-LAB, INC RELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A BIOLAB FRANCHISE COMPANY, LLCRELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A Chemtura CorporationRELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A CROMPTON COLORS INCORPORATEDRELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A RECREATIONAL WATER PRODUCTS, INC RELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A WEBER CITY ROAD LLCRELEASE OF FIRST LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424470508 pdf
Apr 21 2017BANK OF AMERICA, N A RECREATIONAL WATER PRODUCTS, INC RELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A WEBER CITY ROAD LLCRELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A Chemtura CorporationRELEASE OF AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520759 pdf
Apr 21 2017BANK OF AMERICA, N A CROMPTON COLORS INCORPORATEDRELEASE OF AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520759 pdf
Apr 21 2017BANK OF AMERICA, N A GLCC LAUREL, LLCRELEASE OF AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520759 pdf
Apr 21 2017BANK OF AMERICA, N A Great Lakes Chemical CorporationRELEASE OF AMENDED AND RESTATED SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520759 pdf
Apr 21 2017BANK OF AMERICA, N A Chemtura CorporationRELEASE OF THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520894 pdf
Apr 21 2017BANK OF AMERICA, N A CROMPTON COLORS INCORPORATEDRELEASE OF THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520894 pdf
Apr 21 2017BANK OF AMERICA, N A GLCC LAUREL, LLCRELEASE OF THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520894 pdf
Apr 21 2017BANK OF AMERICA, N A LAUREL INDUSTRIES HOLDINGS, INC RELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A HOMECARE LABS, INC RELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A Chemtura CorporationRELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A BIOLAB FRANCHISE COMPANY, LLCRELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A BIO-LAB, INC RELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A CROMPTON COLORS INCORPORATEDRELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A CROMPTON HOLDING CORPORATIONRELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A GLCC LAUREL, LLCRELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A Great Lakes Chemical CorporationRELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A GREAT LAKES CHEMICAL GLOBAL, INC RELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A GT SEED TREATMENT, INC RELEASE OF SECOND LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424490001 pdf
Apr 21 2017BANK OF AMERICA, N A Great Lakes Chemical CorporationRELEASE OF THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT0424520894 pdf
Date Maintenance Fee Events
Jan 02 2013M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Dec 28 2016M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Mar 08 2021REM: Maintenance Fee Reminder Mailed.
Aug 23 2021EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jul 21 20124 years fee payment window open
Jan 21 20136 months grace period start (w surcharge)
Jul 21 2013patent expiry (for year 4)
Jul 21 20152 years to revive unintentionally abandoned end. (for year 4)
Jul 21 20168 years fee payment window open
Jan 21 20176 months grace period start (w surcharge)
Jul 21 2017patent expiry (for year 8)
Jul 21 20192 years to revive unintentionally abandoned end. (for year 8)
Jul 21 202012 years fee payment window open
Jan 21 20216 months grace period start (w surcharge)
Jul 21 2021patent expiry (for year 12)
Jul 21 20232 years to revive unintentionally abandoned end. (for year 12)